Details for New Drug Application (NDA): 205482
✉ Email this page to a colleague
The generic ingredient in OLMESARTAN MEDOXOMIL is amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. There are fifty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil profile page.
Summary for 205482
| Tradename: | OLMESARTAN MEDOXOMIL |
| Applicant: | Jubilant Generics |
| Ingredient: | olmesartan medoxomil |
| Patents: | 0 |
Pharmacology for NDA: 205482
| Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 205482
Suppliers and Packaging for NDA: 205482
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 205482 | ANDA | Jubilant Cadista Pharmacuticals Inc. | 59746-463 | 59746-463-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-463-01) |
| OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 205482 | ANDA | Jubilant Cadista Pharmacuticals Inc. | 59746-463 | 59746-463-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-463-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Apr 24, 2017 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
| Approval Date: | Apr 24, 2017 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
| Approval Date: | Apr 24, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
